Literature DB >> 32256800

Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey.

Xia Zhou1, Hui Shi2, Yuanhua Yang3, Zuoqing Zhang1, Zhenguo Zhai4,5, Chen Wang4,5.   

Abstract

Limited studies have focused on mental symptoms (anxiety and depression) and their impact on quality of life (QoL) in patients with pulmonary hypertension (PH). The objective of the present study was to assess the prevalence of anxiety and depression and their association with QoL in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH) in a Chinese population. Patients diagnosed with PH by right heart catheterization between March 2015 and February 2016 were recruited. QoL [short form 36 Health Survey Questionnaire (SF-36)] and depression (Patient Health Questionnaire depression scale-9) and anxiety (Generalized Anxiety Disorder-7) were assessed at baseline. Patients were followed up every 3 months. A total of 36 patients with PAH and 62 patients with CTEPH were enrolled. According to the results of the clinical examination and the questionnaires for depression and anxiety, patients were divided into two groups: Group 1, with depression and/or anxiety (n=65, 66.3%) and group 2, without depression or anxiety (n=33, 33.7%). At baseline, the two groups did not differ in their hemodynamics. Patients with depression and/or anxiety (group 1) had a significantly lower score in all subscales of SF-36 (P<0.05). The impairment of QoL significantly correlated with the severity of depression (P<0.001) and anxiety (P<0.05). During the follow-up period, end-point events (death or admission due to deterioration) occurred in 17 patients (17.3%); 8 patients (8.1%) were lost to follow-up. The end-point event-free survival rate in group 2 was significantly higher than that in group 1. Multivariate logistic regression analysis suggested that the financial situation and right ventricular enlargement were influencing factors of depression and/or anxiety. In conclusion, in patients with PH from a Chinese population, anxiety and depression were frequently encountered and significantly correlated with QoL. The significant relevant factors influencing anxiety/depression were the financial situation and right ventricular enlargement and patients with depression had a worse prognosis than those without.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  anxiety; depression; influencing factors; pulmonary hypertension; survival

Year:  2020        PMID: 32256800      PMCID: PMC7086277          DOI: 10.3892/etm.2020.8566

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  8 in total

1.  Associated factors with constipation and health-related quality of life in lung cancer patients with platinum-based chemotherapy: A cross-sectional study.

Authors:  Huamao Chen; Xixi Gu; Yan Zhang; Jian Feng; Yan Gu
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

2.  Participation in pulmonary hypertension support group improves patient-reported health quality outcomes: a patient and caregiver survey.

Authors:  Paresh C Giri; Gizelle J Stevens; Jeanette Merrill-Henry; Udochukwu Oyoyo; Vijay P Balasubramanian
Journal:  Pulm Circ       Date:  2021-05-17       Impact factor: 3.017

3.  Physical Activity and Mental Health of Patients with Pulmonary Hypertension during the COVID-19 Pandemic.

Authors:  Carolin Leoni Dobler; Britta Krüger; Jana Strahler; Christopher Weyh; Kristina Gebhardt; Khodr Tello; Hossein Ardeschir Ghofrani; Natascha Sommer; Henning Gall; Manuel Jonas Richter; Karsten Krüger
Journal:  J Clin Med       Date:  2020-12-12       Impact factor: 4.241

4.  Anxiety and Depression in Patients With Pulmonary Arterial Hypertension in Northwest China: A Cross-Sectional Study.

Authors:  Juxia Zhang; Yuhuan Yin; Yujie Wen; Fugui Shi; Jiancheng Wang
Journal:  Front Psychiatry       Date:  2022-02-04       Impact factor: 4.157

5.  Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis.

Authors:  Aaron Shengting Mai; Oliver Zi Hern Lim; Yeung Jek Ho; Gwyneth Kong; Grace En Hui Lim; Cheng Han Ng; Cyrus Ho; Roger Ho; Yinghao Lim; Ivandito Kuntjoro; Edgar Tay; James Yip; Nicholas W S Chew; Ting-Ting Low
Journal:  Front Med (Lausanne)       Date:  2022-02-17

6.  Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Madelaine-Rachel Dering; Nicole Lepsy; Jan Fuge; Tanja Meltendorf; Marius M Hoeper; Ivo Heitland; Jan C Kamp; Da-Hee Park; Manuel J Richter; Henning Gall; Hossein A Ghofrani; Dietmar Ellermeier; Hans-Dieter Kulla; Kai G Kahl; Karen M Olsson
Journal:  Front Psychiatry       Date:  2022-03-02       Impact factor: 4.157

7.  Improving communication between healthcare providers and pulmonary arterial hypertension patients: a survey of patient preferences.

Authors:  Jacqueline Brewer; Mary Bartlett; David Harris; Christine Hui
Journal:  Pulm Circ       Date:  2021-05-21       Impact factor: 3.017

8.  Baseline beliefs about medication are associated with outcomes of antidepressants in inpatients with first-diagnosed depression under supervised therapeutic compliance.

Authors:  Fan-Zhen Kong; Cai-Fang Ji; Xiang-Dong Du; Robert Logan; Hui-Ying Zhao; Guan-Hui Wu; Yan-Song Liu; Zhen Tang; Mei-E Niu
Journal:  Aging (Albany NY)       Date:  2021-09-02       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.